Technology Quarterly | Of bowheads and borzois
Alternatives to the laboratory mouse
Researchers are looking at whales, sparrows and large dogs
Editor’s note (November 29th 2023): On November 28th America’s Food and Drug Administration accepted a “Reasonable Expectation of Effectiveness” application by Loyal, a veterinary-medicine company, for its life-extending drug for large dogs. This is the first time the FDA has recognised the possibility that a drug intended for any species might have general lifespan-extending properties.
This article appeared in the Technology Quarterly section of the print edition under the headline “Of bowheads and borzois ”
From the September 30th 2023 edition
Discover stories from this section and more in the list of contents
Explore the edition